PAI-1 Interaction with Sortilin Related Receptor-1 is Required for Lung Fibrosis
Preprint
Abstract
Plasminogen activator inhibitor-1 (PAI-1) has been previously shown to promote lung fibrosis via a mechanism that requires an intact vitronectin (VTN) binding site. In the present study, employing two distinct murine fibrosis models, we find that VTN is not required for PAI-1 to drive lung scarring. This result suggested the existence of a previously unrecognized profibrotic PAI-1-protein interaction involving the VTN-binding site for PAI-1. Using an unbiased proteomic approach, we identified sortilin related receptor 1 (SorlA) as the most highly enriched PAI-1 interactor in the fibrosing lung. We next investigated the role of SorlA in pulmonary fibrosis and found that SorlA deficiency protected against lung scarring in a murine model. We further show that, while VTN deficiency does not influence fibrogenesis in the presence or absence of PAI-1, SorlA is required for PAI-1 to promote scarring. These results, together with data showing increased SorlA levels in human IPF lung tissue, support a novel mechanism through which the potent profibrotic mediator PAI-1 drives lung fibrosis and implicate SorlA as a new therapeutic target in IPF treatment.Keywords
All Related Versions
- Published version: JCI Insight, 10 (11).
This publication has 58 references indexed in Scilit:
- SORL1 is a receptor for tau that promotes tau seedingJournal of Biological Chemistry, 2024
- VPS10P Domain Receptors: Sorting Out Brain Health and DiseaseTrends in Neurosciences, 2020
- Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1Arthritis & Rheumatology, 2015
- Increased circulating soluble LR11 in patients with acute coronary syndromeClinica Chimica Acta, 2013
- PAI‐1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injuryThe Journal of Pathology, 2012
- Enhanced circulating soluble LR11 in patients with coronary organic stenosisAtherosclerosis, 2010
- PAI‐1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPAFEBS Letters, 2007
- Plasminogen activator inhibitor‐1 regulates cell adhesion by binding to the somatomedin B domain of vitronectinJournal of Cellular Physiology, 2001
- The Development of Bleomycin-Induced Pulmonary Fibrosis in Mice Deficient for Components of the Fibrinolytic SystemThe American Journal of Pathology, 2000
- Molecular evolution of plasminogen activator inhibitor‐1 functional stability.The EMBO Journal, 1995